The Gross Law Firm notifies investors that a class action has commenced in the United States District Court for the Northern District of California on behalf of shareholders of PROCEPT BioRobotics Corporation who purchased Common stock between February 28, 2024 and February 25, 2026.
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (a) during the class period, Procept had utilized an extensive discount program designed to incentivize its customers to place bulk orders in excess of procedure demand; (b) Procept’s undisclosed discount program had artificially and unsustainably inflated the Company’s reported U.S. handpiece unit sales and revenues by pulling forward sales at the expense of future periods; (c) Procept’s undisclosed discount program had caused customer handpiece orders to materially exceed underlying procedure demand throughout the class period and that this differential had materially grown over time; (d) Procept’s consistent surplus of U.S. handpiece unit sales relative to performed procedures had created a glut of field inventory and overstocking amongst Procept’s customer base, amounting to more than 10,000 excess units by the end of the Class Period; (e) as a result of (a)-(d) above, defendants’ representations during the class period regarding Procept’s handpiece unit sales and the utilization of Procept’s field Systems were materially overstated; (f) as a result of (a)-(e) above, Procept was acutely exposed to material undisclosed risks of significant operational and financial harm; and (g) as a result of (a)-(f) above, Procept was unable to achieve its stated 2025 handpiece sales and revenue guidance and such guidance lacked a reasonably achievable factual basis.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in the respective securities during the class periods. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action. Appointment as Lead Plaintiff is not required to partake in any recovery.
Shareholders have until September 22, 2026 to request that the court appoint them lead plaintiff.
To receive more information, please fill out the form.
